Cartesian Therapeutics, Inc. — Director's Dealing 2019

Aug 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-08-20

Reporting Person: Kogan Elona Esq. (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-20	Common Stock	A	82872	$1.81	Acquired	182872	Direct

Footnotes

F1: Total shares reported includes 50,000 shares underlying unvested restricted stock units.